TIDMAMS

RNS Number : 1361X

Advanced Medical Solutions Grp PLC

04 May 2016

4 May 2016

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Directors' Shareholdings

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that the Trust which manages the Deferred Share Bonus Plan on behalf of the employees of AMS has purchased ordinary shares of 5 pence each ("Ordinary Shares") on 3 May 2016, at a price of 183 pence per share on behalf of Chris Meredith and Mary Tavener as part of the Deferred Share Bonus Plan and, under the terms of the Plan, these shares will be held in trust on their behalf.

Following these transactions the beneficial ownership of Chris Meredith and Mary Tavener is as follows:

 
 Director            Date purchased    Shares       Resultant   % of issued 
                                        purchased    holding     share 
                                                                 capital 
==================  ================  ===========  ==========  ============ 
 Chris Meredith 
  Chief Executive    3 May 
  Officer             2016             2,431        1,190,322   0.6 
==================  ================  ===========  ==========  ============ 
 Mary Tavener 
  Chief Financial    3 May 
  Officer             2016             2,431        1,828,129   0.9 
==================  ================  ===========  ==========  ============ 
 
   -     Ends - 

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group         Tel: +44 (0) 
  plc                                      1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications       Tel: +44 (0) 
                                          20 3709 5700 
 Mary-Jane Elliott / Jonathan 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)       Tel: +44 (0) 
                                          20 7597 5970 
 Gary Clarence / Daniel Adams 
  / Patrick Robb 
 

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFIDEIIVIIR

(END) Dow Jones Newswires

May 04, 2016 02:01 ET (06:01 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Advanced Medical Solutions Charts.